Cigna Group (NYSE:CI) Releases FY 2026 Earnings Guidance

Cigna Group (NYSE:CI) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 30.250- for the period, compared to the consensus EPS estimate of 30.350. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on CI shares. Truist Financial boosted their price objective on shares of Cigna Group from $310.00 to $320.00 and gave the stock a “buy” rating in a report on Monday, January 5th. JPMorgan Chase & Co. decreased their target price on Cigna Group from $428.00 to $375.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 4th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $310.00 price target on shares of Cigna Group in a report on Monday, November 3rd. Sanford C. Bernstein reissued a “market perform” rating and set a $307.00 price objective on shares of Cigna Group in a report on Tuesday, January 6th. Finally, Robert W. Baird lowered their price objective on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research report on Thursday, December 11th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $323.16.

Cigna Group Stock Up 2.7%

Shares of NYSE CI opened at $292.29 on Friday. The firm has a market capitalization of $78.08 billion, a price-to-earnings ratio of 13.18, a PEG ratio of 1.01 and a beta of 0.27. The company has a current ratio of 0.74, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The business has a 50-day moving average of $274.77 and a 200-day moving average of $283.95.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. During the same quarter in the previous year, the business earned $6.64 EPS. Cigna Group’s revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts expect that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is 26.64%.

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Q4 earnings and revenue beat — Cigna reported adjusted EPS of $8.08 and revenue of $72.5B, both above consensus, driven by Evernorth growth and higher specialty volumes; investors are rewarding the beat and evidence of durable revenue momentum. Cigna Q4 Highlights
• Positive Sentiment: FTC settlement over insulin pricing reduces regulatory overhang and includes commitments to change PBM pricing practices — this removes a major legal uncertainty and may support multiple expansion. FTC Settlement Coverage
• Positive Sentiment: Dividend increase — the board raised the quarterly dividend to $1.56 (3.3% increase), a modest buyback/dividend-friendly signal that supports income investors. Dividend Announcement
• Neutral Sentiment: Analyst price target moves are mixed — Leerink raised its PT to $297 but kept a “market perform” rating, while RBC trimmed its PT to $333 but maintained an “outperform” view; these moves show cautious optimism but limited near-term upside consensus. Leerink PT Change RBC PT Change
• Neutral Sentiment: Evernorth and specialty volumes are growth drivers cited on the call — supportive for revenue mix and long-term profit potential, though investors will watch margin dynamics. Evernorth Growth Coverage
• Negative Sentiment: 2026 guidance slightly below some Street expectations — Cigna set FY 2026 EPS guidance at at least $30.25, a touch under consensus and accompanied by commentary about ongoing medical-cost and margin pressure; this tempered the upside from the quarter for some investors. Guidance Miss Coverage

Hedge Funds Weigh In On Cigna Group

Several hedge funds have recently added to or reduced their stakes in the company. Sivia Capital Partners LLC grew its position in Cigna Group by 10.4% during the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after acquiring an additional 109 shares during the period. Brighton Jones LLC grew its holdings in Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after purchasing an additional 318 shares in the last quarter. New Vernon Capital Holdings II LLC purchased a new stake in shares of Cigna Group during the third quarter worth about $229,000. Ausdal Financial Partners Inc. acquired a new position in shares of Cigna Group in the 3rd quarter valued at approximately $333,000. Finally, Platinum Investment Management Ltd. raised its stake in Cigna Group by 23.0% during the third quarter. Platinum Investment Management Ltd. now owns 996 shares of the health services provider’s stock valued at $287,000 after buying an additional 186 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.